Skip to Content

Innovator IBD® 50 ETF FFTY

Quantitative rating as of | See Innovator Investment Hub

Morningstar’s Analysis FFTY

Will FFTY outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.



Innovator IBD® 50 ETF earns a Morningstar Quantitative Rating of Negative on the basis of subpar ratings in both the Process and Parent Pillars. The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Unlock our full analysis with Morningstar Investor